We are live on !
Find out more
HighMark Wealth Management Portfolio holdings
AUM
$299M
Turnover
13.67%
1-Year Est. Return
53.01%
This Fund
S&P 500
This Quarter Est. Return
+21.77%
1 Year Est. Return
+53.01%
3 Year Est. Return
+109.68%
5 Year Est. Return
+113.63%
10 Year Est. Return
–
AUM
$299M
AUM Growth
+$52.9M
(+22%)
Cap. Flow
+$8.26M
Cap. Flow % of AUM
Cap. Flow %
2.77%
Top 10 Holdings %
Top 10 Hldgs %
65.82%
Holding
600
New
46
Increased
156
Reduced
94
Closed
36
Avg Time Held
Equity + Options
3.4
years
Top 10 Avg Time Held
Equity + Options
2.7
years
Top 20 Avg Time Held
Equity + Options
2.3
years
Avg Time Held Equity only
3.4
years
Top 10 Avg Time Held Equity only
2.7
years
Top 20 Avg Time Held Equity only
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity MSCI Health Care Index ETF
FHLC
|
+$18.3M |
| 2 |
SI-BONE Inc
SIBN
|
+$3.79M |
| 3 |
Duos Technologies
DUOT
|
+$2.91M |
| 4 |
Apogee Therapeutics
APGE
|
+$2.91M |
| 5 |
Neuropace
NPCE
|
+$1.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$9.41M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$5.14M |
| 3 |
AnaptysBio
ANAB
|
+$3.29M |
| 4 |
iShares MSCI EAFE Value ETF
EFV
|
+$1.64M |
| 5 |
Piper Sandler
PIPR
|
+$1.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 64.9% |
| 2 | Healthcare | 21.84% |
| 3 | Technology | 4.77% |
| 4 | Financials | 3.58% |
| 5 | Industrials | 1.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
276
Xenia Hotels & Resorts
XHR
$1.96B
| $14.6K | ﹤0.01% |
718
| – | – |
2023 Q3
11 quarters
|
|
277
Chipotle Mexican Grill
CMG
$44.8B
| $14.4K | ﹤0.01% |
424
| – | – |
2021 Q1
21 quarters
|
|
278
Philip Morris
PM
$314B
| $14.3K | ﹤0.01% |
79
| – | – |
2019 Q4
26 quarters
|
|
279
RTX Corp
RTX
$259B
| $14.2K | ﹤0.01% |
75
| – | – |
2019 Q4
26 quarters
|
|
280
Southwest Airlines
LUV
$21.7B
| $13.9K | ﹤0.01% |
270
+1
| +0.4% | +$42 |
2022 Q1
17 quarters
|
|
281
Stryker
SYK
$128B
| $13.8K | ﹤0.01% |
44
| – | – |
2019 Q4
26 quarters
|
|
282
iShares Bitcoin Trust
IBIT
$61.9B
| $13.8K | ﹤0.01% |
415
+15
| +4% | +$610 |
2024 Q3
7 quarters
|
|
283
IonQ
IONQ
$11.4B
| $13.6K | ﹤0.01% |
255
-75
| -23% | -$3.8K |
2025 Q2
4 quarters
|
|
284
Invesco Energy Exploration & Production ETF
PXE
$148M
| $13.6K | ﹤0.01% |
400
| – | – |
2022 Q4
14 quarters
|
|
285
Johnson Controls International
JCI
$79.6B
| $13.3K | ﹤0.01% |
91
| – | – |
2020 Q4
22 quarters
|
|
286
CSX Corp
CSX
$94.2B
| $13K | ﹤0.01% |
274
| – | – |
2023 Q2
12 quarters
|
|
287
Lam Research
LRCX
$232B
| $13K | ﹤0.01% |
30
| – | – |
2026 Q1
1 quarter
|
|
288
iShares Russell 1000 Growth ETF
IWF
$113B
| $13K | ﹤0.01% |
104
| – | – |
2019 Q4
26 quarters
|
|
289
Virtus Convertible & Income Fund II
NCZ
$257M
| $12.8K | ﹤0.01% |
805
+18
| +2% | +$275 |
2019 Q4
26 quarters
|
|
290
Salesforce
CRM
$183B
| $12.7K | ﹤0.01% |
81
+46
| +131% | +$8.09K |
2024 Q1
9 quarters
|
|
291
Franco-Nevada
FNV
$48.4B
| $12.5K | ﹤0.01% |
60
| – | – |
2023 Q4
10 quarters
|
|
292
iShares US Regional Banks ETF
IAT
$633M
| $12.4K | ﹤0.01% |
200
| – | – |
2024 Q2
8 quarters
|
|
293
First Trust NASDAQ Cybersecurity ETF
CIBR
$15.7B
| $12.4K | ﹤0.01% |
138
+2
| +1% | +$153 |
2024 Q3
7 quarters
|
|
294
American International
AIG
$42.3B
| $12.4K | ﹤0.01% |
166
| – | – |
2019 Q4
26 quarters
|
|
295
iShares Future AI & Tech ETF
ARTY
$3.13B
| $12.1K | ﹤0.01% |
+159
| New | +$10.5K |
2026 Q2
0 quarters
|
|
296
Crocs
CROX
$6.99B
| $12.1K | ﹤0.01% |
100
| – | – |
2019 Q4
26 quarters
|
|
297
Schwab International Equity ETF
SCHF
$66.2B
| $11.9K | ﹤0.01% |
430
+3
| +0.7% | +$81 |
2023 Q4
10 quarters
|
|
298
First Solar
FSLR
$21B
| $11.8K | ﹤0.01% |
50
| – | – |
2024 Q3
7 quarters
|
|
299
WEC Energy
WEC
$38.9B
| $11.7K | ﹤0.01% |
100
| – | – |
2020 Q4
22 quarters
|
|
300
Amphenol
APH
$177B
| $11.6K | ﹤0.01% |
132
+54
| +69% | +$3.89K |
2025 Q3
3 quarters
|
|
Similar funds
BOC
HighMark Wealth Management's Q2 2026 Portfolio in Review
As of Q2 2026, HighMark Wealth Management held 600 positions worth $299M, up 22% from $246M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
HighMark Wealth Management's Q2 2026 filing shows 46 new, 156 increased, 94 reduced and 36 closed positions. Its largest new stake was Duos Technologies: 289,884 shares worth $3.48M. The largest sale was Centessa Pharmaceuticals, an estimated $9.41M.
By sector, the portfolio is most concentrated in Miscellaneous at 65% of assets, down from 65% a quarter earlier, followed by Healthcare and Technology.
- HighMark Wealth Management's largest Q2 2026 buy was Duos Technologies: 289,884 shares worth $3.48M.
- HighMark Wealth Management added most to Fidelity MSCI Health Care Index ETF in Q2 2026, an estimated $18.3M increase.
- HighMark Wealth Management's biggest Q2 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $5.14M.
- HighMark Wealth Management fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $9.41M.
- HighMark Wealth Management's ten largest holdings make up 66% of its $299M portfolio in Q2 2026.
- HighMark Wealth Management opened 46 new positions and closed 36 in Q2 2026.
- HighMark Wealth Management's portfolio value rose 22% quarter-over-quarter to $299M.
Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.